Menu
You need to have answered the questions for this stock to see this page
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€122.70

€122.70

-1.390%
-1.75
-1.390%
€180.11
 
17.09.24 / Tradegate WKN: 870980 / Symbol: RGEN / Name: Repligen Corp / Stock / Pharmaceuticals / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Repligen Corp. Stock

We can see a decrease in the price for Repligen Corp.. Compared to yesterday it has lost -€1.750 (-1.390%).
With 14 Buy predictions and not the single Sell prediction the community is currently very high on Repligen Corp..
With a target price of 180 € there is a positive potential of 46.7% for Repligen Corp. compared to the current price of 122.7 €.
So far the community has only identified positive things for Repligen Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Repligen Corp. in the next few years

Pros
?
S********** s********
?
B****
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Repligen Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Repligen Corp. -1.390% -5.724% -8.364% -19.488% -26.790% -53.114% 67.600%
Opko Health Inc. 0.760% 7.130% 8.625% -2.492% 5.024% -54.053% -23.916%
Catalent Inc. -0.530% 0.240% 0.742% 23.012% 31.820% -53.581% 18.078%
Amicus Therapeutics Inc. 1.020% -1.000% -3.883% -18.852% -25.000% 5.882% 14.266%

Comments

Prediction Buy
Perf. (%) -20.74%
Target price 184.680
Change
Ends at 31.07.25

Repligen Co. (NASDAQ: RGEN) had its price target raised by analysts at JPMorgan Chase & Co. from $190.00 to $200.00. They now have an "overweight" rating on the stock.
Ratings data for RGEN provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -20.74%
Target price 171.144
Change
Ends at 31.07.25

Repligen Co. (NASDAQ: RGEN) had its price target lowered by analysts at UBS Group AG from $205.00 to $185.00. They now have a "buy" rating on the stock.
Ratings data for RGEN provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -20.74%
Target price 175.541
Change
Ends at 31.07.25

Repligen Co. (NASDAQ: RGEN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $190.00 price target on the stock.
Ratings data for RGEN provided by MarketBeat
Show more